Clinical proteomics: Translating benchside promise into bedside reality

被引：392
|
作者：
Petricoin, EF [1 ]
Zoon, KC
Kohn, EC
Barrett, JC
Liotta, LA
机构：
[1] US FDA, FDA NCI Clin Proteom Program, Div Therapeut Prot, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
[2] US FDA, Off Director, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
[3] NCI, Ctr Canc Res, NIH, FDA NCI Clin Proteom Program,Lab Pathol, Bethesda, MD 20892 USA
来源：
NATURE REVIEWS DRUG DISCOVERY | 2002年 / 1卷 / 09期
关键词：
D O I：
10.1038/nrd891
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The ultimate goal of proteomics is to characterize the information flow through protein networks. This information can be a cause, or a consequence, of disease processes. Clinical proteomics is an exciting new subdiscipline of proteomics that involves the application of proteomic technologies at the bedside, and cancer, in particular, is a model disease for studying such applications. Here, we describe proteomic technologies that are being developed to detect cancer earlier, to discover the next generation of targets and imaging biomarkers, and finally to tailor the therapy to the patient.
引用
收藏
页码：683 / 695
页数：13
相关论文
共 50 条
  • [1] Clinical proteomics: translating benchside promise into bedside reality
    Emanuel F. Petricoin
    Kathryn C. Zoon
    Elise C. Kohn
    J. Carl Barrett
    Lance A. Liotta
    Nature Reviews Drug Discovery, 2002, 1 : 683 - 695
  • [2] Clinical Proteomics: A Promise Becoming Reality
    Gillette, Michael A.
    Jimenez, Connie R.
    Carr, Steven A.
    MOLECULAR & CELLULAR PROTEOMICS, 2024, 23 (02)
  • [3] Targeted Proteomics Comes to the Benchside and the Bedside: Is it Ready for Us?
    Arora, Anjali
    Somasundaram, Kumaravel
    BIOESSAYS, 2019, 41 (02)
  • [4] Osteoinduction: translating preclinical promise into clinical reality
    Ferretti, Carlo
    Ripamonti, Ugo
    Tsiridis, Eleftherios
    Kerawala, Cyrus J.
    Mantalaris, Athanasios
    Heliotis, Manolis
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2010, 48 (07): : 536 - 539
  • [5] 'Benchside-to-Bedside'
    Tsao, Hensin
    English, John
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (05) : 849 - 849
  • [6] Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs
    Gerszten, Robert E.
    Accurso, Frank
    Bernard, Gordon R.
    Caprioli, Richard M.
    Klee, Eric W.
    Klee, George G.
    Kullo, Iftikhar
    Laguna, Theresa A.
    Roth, Frederick P.
    Sabatine, Marc
    Srinivas, Pothur
    Wang, Thomas J.
    Ware, Lorraine B.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 295 (01) : L16 - L22
  • [7] Disease proteomics toward bedside reality
    Toshihide Nishimura
    Atsushi Ogiwara
    Kiyonaga Fujii
    Takao Kawakami
    Takeshi Kawamura
    Hisae Anyouji
    Harubumi Kato
    Journal of Gastroenterology, 2005, 40 : 7 - 13
  • [8] Disease proteomics toward bedside reality
    Nishimura, T
    Ogiwara, A
    Fujii, K
    Kawakami, T
    Kawamura, T
    Anyouji, H
    Kato, H
    JOURNAL OF GASTROENTEROLOGY, 2005, 40 (Suppl 16) : 7 - 13
  • [9] Editorial: Immunogenic Cell death in Cancer: From Benchside research to Bedside reality
    Garg, Abhishek D.
    Agostinis, Patrizia
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [10] Clinical proteomics: Application at the bedside
    Petricoin, EF
    Liotta, LA
    PROTEOMICS IN NEPHROLOGY, 2004, 141 : 93 - 103
12345